XML 14 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Cash Flows - ILS (₪)
₪ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Cash flow from operating activity      
Comprehensive loss for the period ₪ (11,900) ₪ (13,301) ₪ (26,490)
Adjustments required to present cash flows from operating activities (Appendix A) (12) 2,642 3,357
Net cash used in operating activities (11,912) (10,659) (23,133)
Cash flows from investment activity      
Change in restricted deposits (6) (77) (41)
Changes in short-term deposits 5,012 (12,006) (5,012)
Purchase of property and equipment (4) (72) (144)
Net cash provided by (used in) investment activity 5,002 (12,155) (5,197)
Cash flows from financing activity      
Deferred offering expenses (750)
Receipt of government grants 251 579
Net proceeds from issuance of ADS, pre-funded warrants and warrants through initial public offering 37,578
Repayment of principal in respect of lease liability (234) (206) (440)
Exercise of non-registered rights into ordinary shares [1] [1]
Net cash provided by (used in) financing activity 37,344 45 (611)
Change in balance of cash and cash equivalents 30,434 (22,769) (28,941)
Exchange differences on cash and cash equivalents 1,958
Balance of cash and cash equivalents, beginning of period 8,683 37,624 37,624
Balance of cash and cash equivalents, end of period 41,075 14,855 8,683
Appendix A [Member]      
Income and expenses not involving cash flows      
Depreciation 31 28 61
Amortization of right for use asset 212 185 398
Interest expense in respect of leasing 24 30 61
Share-based payment to employees and service providers 545 2,572 3,348
Direct and incremental issuance cost allocated to derivative warrant liability through U.S IPO 723
Revaluation of derivative warrant liability (82)
Exchange differences on cash and cash equivalent (1,958)
Changes in liability in respect of government grants 114 (213)
Income and expenses not involving cash flows total (391) 2,815 3,655
Changes in asset and liability items      
Decrease (increase) in other current assets 201 (376) (647)
Decrease (increase) in trade receivables 127 12 (142)
Increase in inventory (30) (262) (715)
Increase (decrease) in trade payables (164) (63) 54
Increase in other current liabilities 245 516 1,152
Changes in asset and liability total 379 (173) (298)
Income and expenses and changes in asset (12) 2,642 3,357
Appendix B - Non-cash investment and financing activities      
Recognition of right for use asset against a leasing liability 532 532
Deferred offering expenses not yet paid 405
Direct and incremental stock-based payment expenses allocated to ADS and pre-fund warrants through U.S. IPO 960
Offering costs not yet paid 280
Partial exercise of over-allotment option into warrants ₪ 158
[1] Represents an amount lower than NIS 1.